By:
On:
In: Arthritis, Bones & Joints, Blood and Blood Disorders, Doctors and Health Care, Healthy Living, Infectious Disease

MONDAY, Jan. 25, 2021 (HealthDay News) — Full doses of blood thinners can benefit patients hospitalized with COVID-19, but the severity of their illness matters, researchers say. The new global analysis found that hospitalized patients with moderate COVID-19 may benefit from the drugs’ clot-preventing powers, but patients with illness soContinue Reading

By:
On:
In: Arthritis, Bones & Joints, Health & Technology, Infectious Disease, Neurological

WEDNESDAY, Jan. 13, 2021 (HealthDay News) — New research offers a novel explanation for the long-term brain problems many COVID-19 patients experience. Many coronavirus patients report headaches and “brain fog” for weeks or months after they recover from respiratory symptoms. It’s been believed that these lingering neurological issues are theContinue Reading

By:
On:
In: Arthritis, Bones & Joints, Infectious Disease, Medical Disorders

MONDAY, Oct. 26, 2020 (HealthDay News) — When the new coronavirus pandemic first began, respiratory distress immediately became the hallmark of severe COVID-19 illness. News reports focused on the inability to breathe, low oxygen saturation levels and the alarming need for ventilators. But six months later, experts are becoming increasinglyContinue Reading

By:
On:
In: Arthritis, Bones & Joints, Pain and Pain Management

TUESDAY, Oct. 20, 2020 (HealthDay News) — About 30 million U.S. adults live with osteoarthritis and the pain and stiffness it causes, a new survey finds. And nearly one-third of these people said their symptoms are not well-managed, according to the Arthritis Foundation survey of almost 2,000 adults. In osteoarthritis,Continue Reading

By:
On:
In: Arthritis, Bones & Joints, Health & Technology, Medical Disorders, Public Health

MONDAY, Oct. 19, 2020 (HealthDay News) — A recently approved rheumatoid arthritis medication appears to be an effective second-line therapy when biologic treatments start to fail, a new clinical trial reports. Arthritis sufferers treated with upadacitinib had a significantly greater reduction in their symptoms and disease activity than people treatedContinue Reading

By:
On:
In: Arthritis, Bones & Joints, Health & Technology, Hormones and Disease, Infectious Disease, Public Health

FRIDAY, Oct. 9, 2020 (HealthDay News) — The so-called love hormone, oxytocin, may be worth investigating as a treatment for COVID-19, a new study suggests. One of the most serious complications of infection with the new coronavirus is a “cytokine storm,” in which the body attacks its own tissues. ThereContinue Reading